BRAUNISCH, M. C., P. GUNDEL, S. WERFEL, C. C. MAYER, A. BAUER, B. HALLER, R. GUNTHNER, G. LORENZ, S. ANGERMANN, J. MATSCHKAL, C. SCHALLER, C. HOLZMANN-LITTIG, S. KEMMNER, J. MANN, A. KRIETER, L. RENDERS, S. WASSERTHEURER, G. SCHMIDT, U. HEEMANN, Marek MALÍK and C. SCHMADERER. Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients. JOURNAL OF NEPHROLOGY. HEIDELBERG: SPRINGER HEIDELBERG, 2022, vol. 35, No 1, p. 233-244. ISSN 1121-8428. Available from: https://dx.doi.org/10.1007/s40620-021-01068-0.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients
Authors BRAUNISCH, M. C. (guarantor), P. GUNDEL, S. WERFEL, C. C. MAYER, A. BAUER, B. HALLER, R. GUNTHNER, G. LORENZ, S. ANGERMANN, J. MATSCHKAL, C. SCHALLER, C. HOLZMANN-LITTIG, S. KEMMNER, J. MANN, A. KRIETER, L. RENDERS, S. WASSERTHEURER, G. SCHMIDT, U. HEEMANN, Marek MALÍK (203 Czech Republic, belonging to the institution) and C. SCHMADERER.
Edition JOURNAL OF NEPHROLOGY, HEIDELBERG, SPRINGER HEIDELBERG, 2022, 1121-8428.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30217 Urology and nephrology
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.400
RIV identification code RIV/00216224:14110/22:00124939
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s40620-021-01068-0
UT WoS 000652425000003
Keywords in English Left ventricular hypertrophy; Peguero-Lo presti; Cardiovascular mortality; Hemodialysis
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 25/2/2022 10:00.
Abstract
Background In hemodialysis patients, left ventricular hypertrophy (LVH) contributes to high cardiovascular mortality. We examined cardiovascular mortality prediction by the recently proposed Peguero-Lo Presti voltage since it identifies more patients with electrocardiographic (ECG) LVH than Cornell or Sokolow-Lyon voltages. Methods A total of 308 patients on hemodialysis underwent 24 h ECG recordings. LVH parameters were measured before and after dialysis. The primary endpoint of cardiovascular mortality was recorded during a median 3-year follow up. Risk prediction was assessed by Cox regression, both unadjusted and adjusted for the Charlson Comorbidity Index and the Cardiovascular Mortality Risk Score. Results The Peguero-Lo Presti voltage identified with 21% the most patients with positive LVH criteria. All voltages significantly increased during dialysis. Factors such as ultrafiltration rate, Kt/V, body mass index, sex, and phosphate were the most relevant for these changes. During follow-up, 26 cardiovascular deaths occurred. Post-dialysis Peguero-Lo Presti cut-off as well as the Peguero-Lo Presti and Cornell voltages were independently associated with cardiovascular mortality in unadjusted and adjusted analysis. The Sokolow-Lyon voltage was not significantly associated with mortality. An optimal cut-off for the prediction of cardiovascular mortality was estimated at 1.38 mV for the Peguero-Lo Presti. Conclusions The post-dialysis Peguero-Lo Presti cut-off as well as the Peguero-Lo Presti and Cornell voltages allowed independent risk prediction of cardiovascular mortality in hemodialysis patients. Measuring the ECG LVH parameters after dialysis might allow a standardized interpretation as dialysis-specific factors influence the voltages.Y
PrintDisplayed: 23/8/2024 15:54